comparemela.com

Latest Breaking News On - Syncona limited stock exchange - Page 2 : comparemela.com

Syncona : Appoints Roel Bulthuis as Managing Partner

Syncona Ltd, a leading healthcare company focused on creating, building and scaling global leaders in life science, today announces the appointment of Roel Bulthuis as Managing Partner and Head. | April 5, 2023

Eteläuomen läiNoord hollandChris hollowoodRoel bulthuisMerck seronoMsc in biopharmaceutical sciencesSyncona investment managementHelsinki school of economicsMerck groupSyncona ltdFortis bankLeiden universityManaging partnerInkef capitalSenior vice presidentManaging director

Syncona : Mosaic Therapeutics closes $28m series A funding and appoints Brian Gladsden as CEO

Company developing targeted oncology therapies spun out of world-leading research at the Wellcome Sanger Institute, in collaboration with the Netherlands Cancer Institute . | April 4, 2023

United kingdomSouth koreaEmile voestMagdalena jonikasAnne horganMathew garnettKatie odgaardAdrian ibrahimBrian gladsdenInternational cancer genome consortiumSyncona investment management ltdWorldwide leadership teamZyme communicationsBayer agMosaic therapeutics ltdGroup leader

Syncona leads GBP22 5 million financing in Mosaic

Syncona Ltd - healthcare company focused on a portfolio of global leaders in life science - Leads GBP22.5 million Series A financing in Mosaic Therapeutics, a Cambridge England-based oncology. | April 4, 2023

United kingdomJeremy cutlerAlliance newsAlliance news ltdFreeline therapeutics holdingsSyncona ltdMosaic therapeuticsCambridge england basedCambridge innovationGaucher diseaseAll rightsSyncona limited stock exchangePress releaseAmbridge bact gg00b8p59c08

Syncona : Resolution Therapeutics and CCRM sign collaboration agreement to develop and scale up manufacturing for induced pluripotent stem cell (iPSC)-derived macrophage cell therapies

London, UK and Toronto, Canada 7 November, 2022 - Resolution Therapeutics Limited , a biopharmaceutical company developing macrophage cell therapies to treat advanced liver disease, CCRM, one. | November 7, 2022

Province of ontarioUnited kingdomCity ofMitchel sivilottiEdward hodgkinJulia wilsonMichael mayStacey johnsonUniversity of torontoResolution therapeutics limitedOmniabio incUniversity of toronto medicineJw communicationsTherapeutics limitedResolution therapeuticSyncona limited stock exchange

Syncona Shares Rise After Novartis Agrees to Buy Portfolio Company

By Joe Hoppe Syncona Ltd. shares rose Wednesday after it said Novartis AG has agreed to acquire its portfolio company Gyroscope Therapeutics Holdings PLC for up to $1.5 billion. Shares at. | December 22, 2021

City ofUnited kingdomJoe hoppeSyncona ltdGyroscope therapeutics holdingsDow jonesSyncona limited stock exchangePress releaseHares bact gg00b8p59c08

vimarsana © 2020. All Rights Reserved.